Pharmaceutical marketing and innovation in medicines are conducted by Techyon Biotech in India.
Annual revenue $789,389 Latest available
Total funding - Funding intelligence
Employees 38 Tracked headcount
Investors - Known backers
Products 2 Services tracked
Competitors - Brand Intelligence

About Techyon Biotech

Techyon Biotech is a company. The company has 38 employees as of March 29, 2025. Techyon Biotech offers products and services including ONZOLID and Combine-C2.

  • Employees 38 as on 29 Mar, 2025
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Legal Name Techyon Biotech Private Limited
  • Jurisdiction Kanpur, Uttar Pradesh, India
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research Unlock Sub-Sector Unlock Segment
Healthcare → Pharmaceuticals & Therapeutics Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $789.39 K (USD)
    3.4
    as on Mar 31, 2024
  • Net Profit
    $8.68 K (USD)
    211.66
    as on Mar 31, 2024
  • EBITDA
    $86.81 K (USD)
    9.72
    as on Mar 31, 2024
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    38

    as on Mar 29, 2025

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Techyon Biotech

Techyon Biotech offers a comprehensive portfolio of products and services, including ONZOLID and Combine-C2.

Product name locked
Category locked
Primary

ONZOLID is utilized as a medication for combating severe bacterial infections, where effective treatment approaches are applied for patient recovery.

Product name locked
Category locked
Locked

Combine-C2 is employed for addressing osteoarthritis, with an emphasis on affordability to ensure accessible treatment options are provided.

Funding Insights of Techyon Biotech

Premium access

Detailed funding history for Techyon Biotech

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Techyon Biotech

Investments
Premium access

Investment portfolio details for Techyon Biotech

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Techyon Biotech

Premium access

Detailed financials for Techyon Biotech

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Techyon Biotech Comparisons

Techyon Biotech Primary company
Description
Pharmaceutical marketing and innovation in medicines are con...
Location
-
Founded Year
-
Annual Revenue
$789.39 K (USD)
Net Profit
$8.68 K (USD)
EBITDA
$86.81 K (USD)
Employees
38
As of 2025
Premium access

Peer comparison for Techyon Biotech

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Techyon Biotech

Premium access

Detailed competitors of Techyon Biotech

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Techyon Biotech

Premium access

Complete news archive for Techyon Biotech

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Techyon Biotech

As of Mar 29, 2025, the latest employee count at Techyon Biotech is 38.

Annual revenue of Techyon Biotech is $789.39K as on Mar 31, 2024.

Techyon Biotech is identified as a leading pharmaceutical company in India, where partnerships with entities like Akums Drugs and Pharmaceuticals Ltd are formed for manufacturing. A commitment to quality excellence and healthcare innovation is maintained, with divisions such as Chrono-Cure dedicated to chronic disease treatments. The company is steered by principles of accessibility and affordability, fostering collaborations with healthcare professionals, as guided by its directors. Mutual trust with thousands of doctors is built through a focus on satisfaction for both professionals and patients, advancing global healthcare standards.

Techyon Biotech offers ONZOLID and Combine-C2.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available